Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pablo Yepes, PhD"'
Autor:
Julianna K. Bronk, MD, PhD, Ahmad Amer, Swapnil Khose, MD, David Flint, PhD, Antony Adair, PhD, Pablo Yepes, PhD, David Grosshans, MD, PhD, Jason Johnson, MD, Caroline Chung, MD, MSc
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 6, Pp 101044- (2022)
Purpose: We present the case of a 48-year-old patient with recurrent World Health Organization grade II meningioma in the left occipital region who underwent a subtotal resection, followed by postoperative proton therapy to residual disease and the r
Externí odkaz:
https://doaj.org/article/4073d1e5958d4b4d86d1e27f331cc597
Autor:
Mona Kamal, MD, PhD, Christopher Ryan Peeler, PhD, Pablo Yepes, PhD, Abdallah S.R. Mohamed, MD, MSc, Pierre Blanchard, MD, Steven Frank, MD, Lei Chen, PhD, Amit Jethanandani, MPH, Rohit Kuruvilla, MD, Benjamin Greiner, MD, Jared Harp, MD, Robin Granberry, BA, Vivek Mehta, MD, Crosby Rock, MD, Katherine Hutcheson, PhD, Carlos Cardenas, PhD, G.Brandon Gunn, MD, Clifton Fuller, MD, PhD, Dragan Mirkovic, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 1, Pp 111-119 (2020)
Purpose: To evaluate 2 published normal tissue complication probability models for radiation-induced hypothyroidism (RHT) on a large cohort of oropharyngeal carcinoma (OPC) patients who were treated with intensity-modulated radiation therapy (IMRT).
Externí odkaz:
https://doaj.org/article/bb0e7dc103404a9199f4967755b392eb
Autor:
Mike Hernandez, MS, J. Jack Lee, PhD, Beow Y. Yeap, ScD, Rong Ye, MS, Robert L. Foote, MD, Paul Busse, MD, PhD, Samir H. Patel, MD, Roi Dagan, MD, James Snider, MD, Nasiruddin Mohammed, MD, MBA, Alexander Lin, MD, Pierre Blanchard, MD, PhD, Scott B. Cantor, PhD, Menna Y. Teferra, MS, Kate Hutcheson, PhD, Pablo Yepes, PhD, Radhe Mohan, PhD, Zhongxing Liao, MD, Thomas F. DeLaney, MD, Steven J. Frank, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 2, Pp 100635- (2021)
Purpose: This study hypothesized that insurance denial would lead to bias and loss of statistical power when evaluating the results from an intent-to-treat (ITT), per-protocol, and as-treated analyses using a simulated randomized clinical trial compa
Externí odkaz:
https://doaj.org/article/b12c4a70c7db456e8bdeb25effe791bb